Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

This page is alzhub.org's plain-English summary of a published study, not the paper itself. It is generated from the record we hold for this study, sourced and linked below — check the original for the full text and methods.

✓ Peer-reviewed alzhub usefulness score 40 out of 100. Mild cognitive impairment

Topic: Risk, prevention and care in population studies

Age and years of education (YOE) were identified as independent clinical risk factors for PD-MCI. The clinical-radiomics combined model outperformed the radiomics-only model in both the training and test sets, with the model incorporating the right PU (PUR) radiomics features achieving the highest AUC: 0.852 (95% CI: 0.787-0.918) in the training set and 0.790 (95% CI: 0.657-0.923) in the test set. The corresponding F1 scores were 0.704 and 0.667, respectively. Additionally, specific radiomics features showed weak but significant correlations with MoCA scores (P < 0.05). Integration of striatal radiomics features derived from structural MRI images with routine clinical factors demonstrates promising predictive performance for PD-MCI. The proposed clinical-radiomics combined model leverages clinically accessible resources, and its predictive value for PD-MCI establishes a preliminary foundation for subsequent related explorations. However, the model's generalizability remains unconfirmed, further validation on independent datasets is required before any consideration of its clinical application.

Cite this study APA, Vancouver, BibTeX · download .bib or .ris

APA 7th

Chen, H., Debora, A., Wang, H., Xu, J., Zhao, X., Wang, J., et al. (2025). Predicting mild cognitive impairment in patients with Parkinson’s disease by integrating striatal MRI radiomics with clinical features. BMC Medical Imaging. https://doi.org/10.1186/s12880-025-02014-3

Vancouver

Chen H, Debora A, Wang H, Xu J, Zhao X, Wang J, et al. Predicting mild cognitive impairment in patients with Parkinson’s disease by integrating striatal MRI radiomics with clinical features. BMC Medical Imaging. 2025. doi:10.1186/s12880-025-02014-3. PMID: 41239229.

BibTeX

@article{chen2025-41239229,
  author  = {Chen, Haisong and Debora, Asta and Wang, Hongyan and Xu, Jian and Zhao, Xuemiao and Wang, Jingru and Yang, Yunjun and Yu, Mengying},
  title   = {{Predicting mild cognitive impairment in patients with Parkinson’s disease by integrating striatal MRI radiomics with clinical features}},
  journal = {BMC Medical Imaging},
  year    = {2025},
  doi     = {10.1186/s12880-025-02014-3},
  pmid    = {41239229},
  url     = {https://doi.org/10.1186/s12880-025-02014-3}
}

Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record names 8 authors; APA and Vancouver show the first six, BibTeX and the downloads carry all of them. Check the citation against the original before you use it.

Key findings

Why it matters

This study combined striatal MRI radiomics features with clinical factors to predict mild cognitive impairment in Parkinson's disease, with the best model reaching an AUC of 0.852 in training and 0.790 in testing. The authors state the model's generalizability is unconfirmed and further validation is required before any consideration of clinical application.

Study details

How this study scored 40/100
How this study's score is builtJournal tier 7 of 10; Journal's citation record 0 of 4; Study design 0 of 12; Strength of evidence 1 of 5; Peer-review validation 10 of 10; How recent 4 of 5; Sample size 3 of 4; Effect reported 3 of 3; Studied in people 3 of 3; Randomised / blinded 0 of 2; Times cited 1 of 7; Citations per year 1 of 5; Impact for its field and year 2 of 6; Cited by studies here 0 of 6; Still being cited 1 of 4; Senior author's track record 0 of 4; Institution's track record 0 of 3; Multi-centre collaboration 0 of 3; Indexed in PubMed 2 of 2; Free to read 2 of 2. Total 40 of 100.40 of 100 points earned60 not earned

Published in a peer-reviewed journal. Scored zero for study design and randomised / blinded because the record does not state it.

ComponentPointsWhy
Journal tier 7 / 10 Tier 3 — peer-reviewed journal (BMC Medical Imaging)
Journal's citation record 0 / 4 BMC Medical Imaging: journal h-index 74 (OpenAlex, 2026-10-29)
Study design 0 / 12 No study design recorded — scores zero, not guessed (not stated in the record — scored 0)
Strength of evidence 1 / 5 Rated “low” in our summary
Peer-review validation 10 / 10 Peer-reviewed. Published as an article in a named peer-reviewed journal.
How recent 4 / 5 2025 — within 3 year(s) of the newest study here
Sample size 3 / 4 1,316 participants
Effect reported 3 / 3 Effect reported with a statistic (interval, p-value, ratio or similar)
Studied in people 3 / 3 Studied in people (participant count stated)
Randomised / blinded 0 / 2 No randomisation or blinding stated — scores zero (not stated in the record — scored 0)
Times cited 1 / 7 Cited 3 times (OpenAlex, 2026-10-10)
Citations per year 1 / 5 1.0 citations a year over 3 year(s) since 2025
Impact for its field and year 2 / 6 Cited 1.6× the average for papers of its field and year (OpenAlex FWCI)
Cited by studies here 0 / 6 No other study in this library cites it
Still being cited 1 / 4 Cited 3 times in 2024–2026 (2026 still in progress; OpenAlex)
Senior author's track record 0 / 4 Last-listed author Mengying Yu: h-index 3 (OpenAlex, whole career)
Institution's track record 0 / 3 First Affiliated Hospital of Wenzhou Medical University: institution h-index 263 (OpenAlex)
Multi-centre collaboration 0 / 3 OpenAlex lists 1 institution(s) in 1 country — scores zero (affiliation lists can be incomplete)
Indexed in PubMed 2 / 2 Indexed in PubMed (PMID 41239229)
Free to read 2 / 2 Free to read
Total 40 / 100 —

What each of these 20 components measures, and what this score is not →

Read the original

Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).

Studies this one cites

Referenced by this study and also in the alzhub library, so you can read them here.

Related studies in Mild cognitive impairment

Also tagged “examination”

840 studies in the library carry the topic tag “examination”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 840 tagged studies.

Similar studies

More on Mild cognitive impairment

See all studies in Mild cognitive impairment →